The clinical trial industry is receiving an influx of interest from US and European biotech and medical companies. Medical research companies from the United States and Europe are starting to shift clinical trials to New Zealand because of its lack of Covid-19 restrictions. Christian Schwabe, managing director of medical research site Auckland Clinical Studies, said New Zealand was already starting to attract phase 1 and 2 clinical trials before the coronavirus hit. But now that many clinical trials are on hold in North America and Europe due to coronavirus, sponsors were looking at New Zealand to transfer or starting trials. Clinical trial interest is so great that the 35 beds at Auckland Clinical Studies were full, he said.

Source: Stuff December 03, 2020 03:11 UTC